Delivery Order SPE2DB24D2011-SPE2DB25FBNXX
Award Date
10/15/24
Potential Completion Date
10/16/24
Potential Value
$54K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a $28,351.01 firm-fixed-price delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,924,502 units of the drug Dupixent 300 mg/2 mL pen. This order was placed under an existing Indefinite Delivery Contract (IDC) valued up to $999,999,999 between DLA Troop Support Medical and AmerisourceBergen, which provides a broad range of medical commodities to support military treatment facilities and programs...
The Defense Logistics Agency (DLA) awarded a $6,175.01 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,753,870 units of Dupixent 300 mg/2 ml pens. This contract, which does not have a set-aside designation, has an ultimate completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these critical pharmaceutical products to support various military treatment...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The $14,117.12 contract is for the supply of Dupixent 300 mg/2 ml pen medication. This award is part of a larger indefinite delivery contract (IDC) between DLA Troop Support Medical and AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary vehicle...
The U.S. Defense Logistics Agency (DLA) awarded a $3,475.70 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Dupixent 300 mg/2 ml pens. The delivery order is part of a larger $999,999,999.00 single-award Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corporation's Corporate Office division to supply the pharmaceutical product Dupixent 300 mg/2 ml pen (2 ml). The contract, valued at $37,165.78, has a firm fixed price and is scheduled for completion by September 16, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued up to $999,999,999 through December...
The U.S. Defense Logistics Agency (DLA) awarded a $9,279.63 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,286,655 units of the drug Dupixent 300 mg/2 ml syringe. This contract has a period of performance through July 30, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, to provide a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a $16,824.83 firm-fixed-price delivery order contract (SPE2DB22D3004|SPE2DB24FPN96) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide 4,563,862,706 units of the medication Dupixent 300 mg/2 ml pen. The contract has an ultimate completion date of March 6, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $24,419.18 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has a completion date of February 3, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $14,684.24, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription drug Dupixent (300 mg/2 ml pen, 2 ml) to support U.S. government medical programs. The contract is a firm-fixed-price delivery order with a completion date of June 21, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 4,563,943,360 units of the pharmaceutical product Dupixent 300 mg/2 ml pen. The contract has a ceiling value of $40,898.97 and a period of performance through March 13, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract with DLA, valued at up to...